IA META: COME OPPORSI ALL'USO DEI DATI DEGLI UTENTI Avv. Federica Fantauzzo Avvocati Liberi Con il comunicato stampa del 29.4.2025 (https://www.garanteprivacy.it/home/docweb/-/docweb-display/docweb/10125702), il Garante per la Protezione dei Dati Personali ha informato che da fine maggio 2025, Meta (società che controlla i servizi di rete sociale Facebook e Instagram, i servizi di messaggistica istantanea WhatsApp e Messenger e sviluppa i visori di realtà virtuale Oculus Rift) addestrerà i suoi sistemi utilizzando i dati personali degli utenti che non si saranno opposti. Il Garante informa che "Gli utenti di Facebook e Instagram – e i non utenti i cui dati possono essere comunque presenti sulle due piattaforme perché pubblicati da utenti - hanno il diritto di opporsi al trattamento dei propri dati personali per l’addestramento dell’intelligenza artificiale di Meta, utilizzando i moduli resi disponibili online dalla società. Tale diritto, riconosciuto dal GDPR – il Regolamento europeo sulla protezione dei dati personali -, è esercitabile anche nei confronti di altri sistemi di IA, come, ad es. quelli di OpenAI, DeepSeek e Google". Senza l'opposizione da parte dell'utente, Meta utilizzerà "i dati contenuti nei post pubblici degli utenti maggiorenni (post, commenti, didascalie, foto, etc.) e quelli derivanti dall’utilizzo dei propri servizi di IA (ad es: informazioni inserite nel suo agente conversazionale su WhatsApp), per sviluppare e migliorare il chatbot Meta AI su WhatsApp o i modelli linguistici come Llama.". Il diritto di opposizione è esercitabile compilando i moduli disponibili ai seguenti link: 👉Opposizione al trattamento per gli utenti Facebook: https://www.facebook.com/help/contact/712876720715583 👉Opposizione al trattamento per gli utenti Instagram: https://help.instagram.com/contact/767264225370182 👉Opposizione al trattamento per gli interessati che non utilizzano i prodotti Meta (senza login): https://www.facebook.com/help/contact/510058597920541 Il Garante precisa che "L’opposizione, se esercitata entro fine maggio, permette di sottrarre all’addestramento dell’intelligenza artificiale di Meta tutte le informazioni personali, mentre se esercitata successivamente interesserà solo i contenuti pubblicati successivamente e non quelli già online. In caso di mancata opposizione, Meta utilizzerà tutti i predetti dati per l’addestramento delle proprie intelligenze artificiali". Fonte: 👇❤️👇 https://t.me/avvocati_liberi)

The global Breast Cancer Therapy Market is witnessing significant momentum as innovative treatment approaches, rising disease awareness, and supportive healthcare policies converge to redefine patient outcomes. With an increasing number of breast cancer cases reported worldwide, the demand for effective diagnostic and therapeutic solutions continues to rise, driving rapid advancements in oncology treatment protocols. Market Overview The global Breast Cancer Therapy market size is expected to reach USD 63.13 billion by 2032, according to a new study by Polaris Market Research. The market encompasses a wide range of treatment modalities including chemotherapy, hormonal therapy, targeted therapy, immunotherapy, and radiation therapy. Key therapeutic innovations and rising investment in cancer research are accelerating market growth, with emerging players and established pharmaceutical companies launching new drug formulations and personalized treatments. Key Market Growth Drivers 1. Rising Global Incidence of Breast Cancer According to the World Health Organization (WHO), breast cancer has surpassed lung cancer as the most commonly diagnosed cancer globally. In 2024 alone, over 2.3 million women were diagnosed with breast cancer, making it a leading cause of cancer-related deaths among females. This soaring incidence is a primary driver of therapy demand, leading to increased screening programs and early detection initiatives. 2. Advancements in Targeted and Immunotherapies Breakthroughs in targeted therapy and cancer immunotherapy are transforming the treatment landscape. Medications like trastuzumab, pertuzumab, palbociclib, and newer checkpoint inhibitors offer improved efficacy and fewer side effects compared to traditional chemotherapy. The integration of biomarkers and companion diagnostics has further enhanced the precision of treatment delivery. 3. Government and Private Sector Investment Growing government support and private sector funding in oncology research and clinical trials are fueling the development of novel breast cancer drugs. Initiatives such as the Cancer Moonshot program in the United States and the EU’s Horizon Europe research funding have mobilized substantial resources for cancer therapy innovation. 4. Rising Awareness and Early Detection Campaigns Public health campaigns, advocacy by non-profits such as the Susan G. Komen Foundation and Breast Cancer Now, and corporate social responsibility initiatives are boosting awareness, reducing stigma, and encouraging early screening. Earlier diagnosis significantly improves treatment outcomes, thereby increasing the adoption of therapy solutions. 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/breast-cancer-therapy-market Market Challenges Despite the growth trajectory, the breast cancer therapy market faces several obstacles: 1. High Treatment Costs Advanced therapies, particularly biologics and immunotherapies, come with high price tags. The cost burden poses challenges for patients in low-income regions and contributes to inequality in access to treatment. Even in developed economies, the affordability of newer therapies remains a concern for uninsured or underinsured populations. 2. Adverse Effects and Drug Resistance Chemotherapy and radiation therapy often lead to severe side effects, such as nausea, fatigue, and hair loss, affecting the patient’s quality of life. Additionally, drug resistance in metastatic breast cancer limits the long-term effectiveness of certain treatments, prompting the need for ongoing drug innovation and combination therapies. 3. Complex Regulatory Approvals Securing regulatory approvals for new cancer drugs involves rigorous clinical testing and time-intensive documentation. Delays in approval can restrict the timely introduction of promising treatments into the market. 4. Limited Access in Emerging Economies Healthcare infrastructure challenges in many developing countries, along with lack of trained oncologists and inadequate insurance coverage, limit the adoption of advanced breast cancer therapies in these regions. Regional Analysis North America North America holds the largest share of the global market, driven by high awareness, early diagnosis rates, and the availability of advanced healthcare infrastructure. The United States, in particular, is a dominant player, with strong R&D activity, a robust clinical trial pipeline, and the presence of major pharmaceutical companies like Pfizer, Roche, and Eli Lilly. Europe Europe is the second-largest market, with countries such as Germany, France, and the United Kingdom showing strong demand for targeted and hormonal therapies. Government-funded cancer research programs and national screening guidelines contribute to market expansion. Asia Pacific The Asia Pacific region is experiencing the fastest growth due to rising cancer prevalence, improved access to healthcare, and increased investment by global pharmaceutical companies. China, India, and Japan are emerging as high-potential markets, particularly in urban centers where awareness and healthcare access are improving. Latin America & Middle East These regions are gradually expanding due to enhanced health policies and international health aid. However, limited access to advanced therapies and diagnostic tools remains a hurdle. Key Companies in the Breast Cancer Therapy Market Several leading companies are at the forefront of innovation and market development: 1. Roche Holding AG Roche is a global leader in oncology, with a robust portfolio that includes Herceptin, Perjeta, and Kadcyla. The company continues to invest heavily in targeted therapies and personalized treatment approaches. 2. Pfizer Inc. Pfizer has significantly contributed to the breast cancer treatment space with drugs like Ibrance (palbociclib), a CDK 4/6 inhibitor that has changed the standard of care for HR-positive, HER2-negative metastatic breast cancer. 3. AstraZeneca AstraZeneca’s focus on precision oncology is evident in its pipeline of antibody-drug conjugates (ADCs) and the success of Enhertu, developed in partnership with Daiichi Sankyo. The company is also exploring combination therapies to overcome drug resistance. 4. Eli Lilly and Company Eli Lilly has expanded its oncology portfolio with Verzenio (abemaciclib), another CDK4/6 inhibitor that has shown promise in both early-stage and advanced breast cancer cases. 5. Novartis AG Novartis plays a major role with its Kisqali (ribociclib) and a deep research pipeline targeting hormone receptor-positive subtypes. The company emphasizes access programs in low- and middle-income countries. 6. Gilead Sciences Gilead entered the breast cancer therapy space through its acquisition of Immunomedics and its groundbreaking ADC, Trodelvy, targeting triple-negative breast cancer. Future Outlook The breast cancer therapy market is poised for transformative change as new technologies—including AI-driven diagnostics, genomic profiling, and nanotechnology-based drug delivery systems—gain traction. Moreover, as personalized medicine becomes more central to oncology treatment strategies, the focus will shift to tailored drug combinations, real-world evidence integration, and patient-centric care models. More Trending Latest Reports By Polaris Market Research: Hair Styling Products Market Guns and Accessories Market Hematologic Malignancies Therapeutics Market Thermal Spray Coatings Market Latin America Industrial Pumps Market Enteric Empty Capsules Market Snow Sport Accessories Market High Frequency Trading Servers Market Vascular Stent Market

Prove generali di controllo globale! CONTINUA a PAGARE con LA CARTA o il BANCOMAT, ma SAPPI che SENZA CONTANTI non potrai FARE PIU' NULLA. MASSIMA CONDIVISIONE! ECCO COSA E' SUCCESSO in SPAGNA, PORTOGALLO e SUD della FRANCIA! E questa è solo una delle conseguenze. Source: https://www.instagram.com/reel/DJCERi2o3NS/?igsh=Z3pueTF2cTB2anlw

QUESTO SIGNIFICA PARLAR CHIARO! Il vice primo ministro serbo Aleksandar Vulin ha dichiarato a RIA Novosti che l'UE ha deciso di imporre sanzioni nei suoi confronti, vietandogli l'ingresso nei Paesi dell'Unione. Mercoledì scorso Vulin aveva dichiarato al Parlamento europeo che la Serbia non entrerà mai in guerra con la Russia in cambio dell'adesione all'UE. Ha detto che la Serbia per 20 anni ha soddisfatto “ogni desiderio e richiesta” dell'UE, ma gli è stato detto che il blocco ammetterà l'Ucraina e la Moldavia come prossimi membri, anche se non hanno ancora soddisfatto una sola condizione per entrare. Vulin aveva anche respinto la richiesta di imporre sanzioni alla Russia. La Serbia non “non scenderà così in basso da imporre sanzioni alla Russia a causa di un conflitto che si sarebbe potuto evitare se solo aveste rispettato gli accordi di Minsk”. Ha inoltre dichiarato alla TASS che Bruxelles ha elaborato un piano per rovesciare il presidente serbo Aleksandar Vucic con il sostegno dei servizi segreti occidentali. @LauraRuHK THIS IS CLEAR! Serbian Deputy Prime Minister Aleksandar Vulin told RIA Novosti that the EU has decided to impose sanctions on him, banning him from entering the EU. Vulin told the European Parliament on Wednesday that Serbia would never go to war with Russia in exchange for EU membership. He said that Serbia had fulfilled “every wish and request” of the EU for 20 years, but was told that the bloc would admit Ukraine and Moldova as future members, even though they had not yet met a single condition for membership. Vulin also rejected the call to impose sanctions on Russia. Serbia “will not stoop so low as to impose sanctions on Russia because of a conflict that could have been avoided if only you had respected the Minsk agreements.” He also told TASS that Brussels had drawn up a plan to overthrow Serbian President Aleksandar Vucic with the support of Western intelligence services. @LauraRuHK Fonte: https://t.me/fdonato/1684

The Alaska Airlines Seattle office, located at Seattle-Tacoma International Airport, provides assistance with flight bookings, check-ins, and baggage issues. Open 24/7, it ensures travelers receive the support they need for a smooth journey through Seattle. https://www.airlinesticketoffice.com/alaska-airlines/alaska-airlines-seattle-office-in-usa/

CONDIVIDO IN TOTO È ORA DI SCIOGLIERE LA COMMISSIONE EUROPEA L'eurodeputato Harald Vilimsky dice la verità: "Rifiutiamo questa commissione... è a favore delle migrazioni di massa, della privazione della libertà, del bellicismo, della deindustrializzazione e del declino dell'Europa." L'Europa non ha bisogno della Commissione Europea. Si tratta di un ostacolo burocratico non eletto: un'élite tecnocratica che si oppone alla volontà del popolo. LA DEMOCRAZIA NON HA BISOGNO DI URSULA VON DER LEYEN — LA DEMOCRAZIA HA BISOGNO DELLA LIBERTÀ. COSA SIGNIFICA: Migrazioni di massa progettate da funzionari non eletti. Libertà sacrificata in nome del controllo e della conformità. L’industria europea è stata sventrata per scelta, non per caso. Il Parlamento europeo deve essere al servizio dei cittadini, non sottomettersi ai burocrati. È tempo di cacciare i tecnocrati, porre fine alla Commissione e riprendersi il futuro dell'Europa. L'EUROPA APPARTIENE ALLE SUE NAZIONI, NON AI GLOBALISTI NON ELETTI. AGREE TOTALLY IT'S TIME TO DISSOLVE THE EUROPEAN COMMISSION MEP Harald Vilimsky speaks the truth: "We reject this commission... it is in favor of mass migration, deprivation of liberty, warmongering, deindustrialization and the decline of Europe." Europe does not need the European Commission. It is an unelected bureaucratic obstacle: a technocratic elite that opposes the will of the people. DEMOCRACY DOES NOT NEED URSULA VON DER LEYEN — DEMOCRACY NEEDS FREEDOM. WHAT IT MEANS: Mass migrations engineered by unelected officials. Freedom sacrificed in the name of control and compliance. European industry has been gutted by choice, not by accident. The European Parliament must serve the citizens, not submit to bureaucrats. It is time to kick out the technocrats, end the Commission and take back Europe's future. EUROPE BELONGS TO ITS NATIONS, NOT TO UNELECTED GLOBALISTS. Source: https://x.com/OrtigiaP/status/1917125441862635740?t=CqPq-HrgbJ5qF_B1pjmgrg&s=19

Buy Nicotine Pouches in Bulk-Flavored Nicotine Pouches Dubai Looking to buy nicotine pouches in bulk? Swedish Origin offers premium options with a wide variety of flavors crafted to suit every taste preference. From refreshing mint to fruity and classic blends, each pouch is designed for smooth, tobacco-free satisfaction. Made to Swedish quality standards, our products are discreet, smoke-free, and perfect for any lifestyle. Whether you’re stocking up for retail, wholesale, or personal use, Swedish Origin ensures top-quality products with fast delivery and competitive prices. Explore the best flavored nicotine pouches in Dubai and discover your new favorite flavor today: https://www.swedishorigin.com/flavoured-nicotine-pouches

Is PVC printing film suitable for outdoor use? 🌦️ Discover how Shanghai MSD's PVC film withstands UV rays, rain, and temperature changes—ideal for durable outdoor signage and graphics. 🔗 #PVCPrintingFilm #OutdoorSignage #ShanghaiMSD​

Dekton Kitchen Worktops – A Cutting-Edge Solution from Granite Supply Dekton kitchen worktops from Granite Supply are the epitome of innovation and luxury. Made from ultra-compact material, Dekton offers unrivalled strength and resistance to heat, scratches, and stains, making it the ideal choice for busy kitchens. Its versatility in design means you can find the perfect style that complements your home. At Granite Supply, we offer premium dekton kitchen worktops that provide a sleek and contemporary finish to any kitchen. Perfect for those who appreciate both style and functionality, Dekton worktops will elevate your space for years to come. Contact us now to explore our range of Dekton kitchen worktops and experience the cutting-edge solution for your home! Visit:- https://www.granitesupply.co.uk/dekton-worktops/

Which Blood Pressure Medications Cause ED (Erectile Dysfunction)?